A new FDA program will use a two-phase approach to help boost domestic drug manufacturing, while OpenAI is leaning into health care with the launch of GPT-5.

Elizabeth Booker Houston, an American lawyer, public health professional, political commentator and standup comedian, has gone viral after announcing online that she had left her job at the Food and ...

The FDA’s top vaccine regulator is returning to his post less than 2 weeks after the White House had him ousted.

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

A unanimous panel, including the FDA commissioner, says the black box warnings are outdated and need to be removed by the FDA ...

For years, state lawmakers have taken the lead on regulating kratom — the controversial herbal supplement used for pain ...

Botanic Tonics defends its kratom products as safe, asserting they are not affected by the FDA's crackdown focused on ...

In our Venable FDA Pulse series, we report on critical developments within the Food and Drug Administration (FDA or the Agency) that may affect ...

The end of the IV saline shortage follows another removal from the FDA’s shortage list in mid-July. Then, the agency removed ...

Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...

President Trump’s effort to lessen crime in Washington, D.C., and launch a “beautification” effort is clashing with a long tradition of Republicans criticizing and outright writing off the ...